Clene Inc. (CLNN) stock
CLNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.92−0.08 (-2.00%)
Close on Nov 13, 2026Market cap $50.37MP/E –Yield –
Clene enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Clene's enterprise value was $49.28M on Nov 11, 2026, against $102.55M a year earlier. Over the last 5 years it ranged from $3.10M to $209.69M, with a median of $52.03M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $49.28M | -13.0% |
| 2025 | Dec 31, 2025 | $56.66M | +141.3% |
| 2024 | Dec 31, 2024 | $23.48M | +657.7% |
| 2023 | Dec 29, 2023 | $3.10M | -94.1% |
| 2022 | Dec 30, 2022 | $52.69M | -74.8% |
| 2021 | Dec 31, 2021 | $208.99M | +41.0% |
| 2020 | Dec 31, 2020 | $148.24M | – |
See a number that looks wrong?